| Name | Title | Contact Details |
|---|
Accredited by The Joint Commission, Stanly Regional is governed by a volunteer board of directors representing both Stanly and Montgomery counties. Our main campus is a 109-bed medical facility consisting of 97 general acute beds, 10 rehabilitation beds and 12 behavioral health beds. With a staff of healthcare professionals using the latest medical treatments and technology, Stanly Regional Medical Center offers advancements in cancer treatment, imaging, rehabilitation, women`s services and more. For outstanding medical care from professionals you know and trust, look no further. We`re right beside you.
American Well transforms healthcare delivery through telehealth. We make online doctor visits accessible to everyone for one-off care issues like colds or infections, and chronic condition management, such as diabetes or depression. We deliver healthcare into people`s homes and workplaces through our work with top health plans, health systems and employers, as well as our telehealth app, Amwell. A patient using Amwell can connect to a board-certified doctor of their choosing in just minutes for a visit carried out over smartphone, tablet, kiosk, phone, or desktop.
NUCATS provides scientists with consultative resources and expertise in order to accelerate how quickly transformative scientific discoveries make their way to patients and the community. It is our goal to continually increase the quality, safety, efficiency and speed of innovative clinical and translational research.
Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.
We consistently strive to deliver unparalleled service, high quality results.